Transoral resection for squamous cell carcinoma of the base of the tongue

Douglas K. Henstrom, Eric J. Moore, Kerry D. Olsen, Jan Kasperbauer, Michaela E. McGree

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Objective: To review the oncologic and functional outcomes of patients with squamous cell carcinoma of the base of the tongue who underwent transoral tumor resection and neck dissection with or without postoperative adjuvant therapy. Design: Retrospective medical record review. Setting: Tertiary referral center. Patients: All patients undergoing transoral resection of squamous cell carcinoma on the base of the tongue as part of their primary treatment from January 1, 1996, through January 31, 2005. Main Outcome Measures: We analyzed overall survival, disease-specific survival, local control, and locoregional control rates using the Kaplan-Meier method. Speech and swallowing function and treatment-related morbidity were also analyzed. Results: A total of 20 patients underwent transoral resection. Four patients had surgery only, 12 had surgery and radiotherapy, and 4 had surgery and chemoradiotherapy. One patient had stage II disease, 3 had stage III disease, and 16 had stage IVA disease. The Kaplan-Meier overall survival rate was 90.0%, and the diseasespecific survival rate was 94.7% at 2 years, with a mean follow-up of 3.7 years. Median hospital stay was 4.7 days. Patients who received a tracheostomy underwent decannulation with a median tracheostomy time of 5.5 days. Seven of 9 patients who received a percutaneous endoscopic gastrostomy tube had it removed. Three patients developed local recurrence, there were no regional recurrences, and 2 patients developed distant metastasis. Conclusions: Transoral resection of squamous cell carcinoma of the base of the tongue with postoperative adjuvant therapy provided excellent local and regional control and minimized morbidity. Transoral resection is a reasonable treatment option for patients with oropharyngeal squamous cell carcinoma, resulting in very low overall loss of organ function in properly selected patients.

Original languageEnglish (US)
Pages (from-to)1231-1238
Number of pages8
JournalArchives of Otolaryngology - Head and Neck Surgery
Volume135
Issue number12
DOIs
StatePublished - Dec 1 2009

Fingerprint

Tongue
Squamous Cell Carcinoma
Tracheostomy
Survival Rate
Morbidity
Therapeutics
Recurrence
Neck Dissection
Gastrostomy
Survival
Chemoradiotherapy
Deglutition
Tertiary Care Centers
Medical Records
Length of Stay
Radiotherapy
Outcome Assessment (Health Care)
Neoplasm Metastasis

ASJC Scopus subject areas

  • Surgery
  • Otorhinolaryngology

Cite this

Transoral resection for squamous cell carcinoma of the base of the tongue. / Henstrom, Douglas K.; Moore, Eric J.; Olsen, Kerry D.; Kasperbauer, Jan; McGree, Michaela E.

In: Archives of Otolaryngology - Head and Neck Surgery, Vol. 135, No. 12, 01.12.2009, p. 1231-1238.

Research output: Contribution to journalArticle

Henstrom, Douglas K. ; Moore, Eric J. ; Olsen, Kerry D. ; Kasperbauer, Jan ; McGree, Michaela E. / Transoral resection for squamous cell carcinoma of the base of the tongue. In: Archives of Otolaryngology - Head and Neck Surgery. 2009 ; Vol. 135, No. 12. pp. 1231-1238.
@article{0e1bc76903b24aa5bc571b31af0fcf9c,
title = "Transoral resection for squamous cell carcinoma of the base of the tongue",
abstract = "Objective: To review the oncologic and functional outcomes of patients with squamous cell carcinoma of the base of the tongue who underwent transoral tumor resection and neck dissection with or without postoperative adjuvant therapy. Design: Retrospective medical record review. Setting: Tertiary referral center. Patients: All patients undergoing transoral resection of squamous cell carcinoma on the base of the tongue as part of their primary treatment from January 1, 1996, through January 31, 2005. Main Outcome Measures: We analyzed overall survival, disease-specific survival, local control, and locoregional control rates using the Kaplan-Meier method. Speech and swallowing function and treatment-related morbidity were also analyzed. Results: A total of 20 patients underwent transoral resection. Four patients had surgery only, 12 had surgery and radiotherapy, and 4 had surgery and chemoradiotherapy. One patient had stage II disease, 3 had stage III disease, and 16 had stage IVA disease. The Kaplan-Meier overall survival rate was 90.0{\%}, and the diseasespecific survival rate was 94.7{\%} at 2 years, with a mean follow-up of 3.7 years. Median hospital stay was 4.7 days. Patients who received a tracheostomy underwent decannulation with a median tracheostomy time of 5.5 days. Seven of 9 patients who received a percutaneous endoscopic gastrostomy tube had it removed. Three patients developed local recurrence, there were no regional recurrences, and 2 patients developed distant metastasis. Conclusions: Transoral resection of squamous cell carcinoma of the base of the tongue with postoperative adjuvant therapy provided excellent local and regional control and minimized morbidity. Transoral resection is a reasonable treatment option for patients with oropharyngeal squamous cell carcinoma, resulting in very low overall loss of organ function in properly selected patients.",
author = "Henstrom, {Douglas K.} and Moore, {Eric J.} and Olsen, {Kerry D.} and Jan Kasperbauer and McGree, {Michaela E.}",
year = "2009",
month = "12",
day = "1",
doi = "10.1001/archoto.2009.177",
language = "English (US)",
volume = "135",
pages = "1231--1238",
journal = "JAMA Otolaryngology - Head and Neck Surgery",
issn = "2168-6181",
publisher = "American Medical Association",
number = "12",

}

TY - JOUR

T1 - Transoral resection for squamous cell carcinoma of the base of the tongue

AU - Henstrom, Douglas K.

AU - Moore, Eric J.

AU - Olsen, Kerry D.

AU - Kasperbauer, Jan

AU - McGree, Michaela E.

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Objective: To review the oncologic and functional outcomes of patients with squamous cell carcinoma of the base of the tongue who underwent transoral tumor resection and neck dissection with or without postoperative adjuvant therapy. Design: Retrospective medical record review. Setting: Tertiary referral center. Patients: All patients undergoing transoral resection of squamous cell carcinoma on the base of the tongue as part of their primary treatment from January 1, 1996, through January 31, 2005. Main Outcome Measures: We analyzed overall survival, disease-specific survival, local control, and locoregional control rates using the Kaplan-Meier method. Speech and swallowing function and treatment-related morbidity were also analyzed. Results: A total of 20 patients underwent transoral resection. Four patients had surgery only, 12 had surgery and radiotherapy, and 4 had surgery and chemoradiotherapy. One patient had stage II disease, 3 had stage III disease, and 16 had stage IVA disease. The Kaplan-Meier overall survival rate was 90.0%, and the diseasespecific survival rate was 94.7% at 2 years, with a mean follow-up of 3.7 years. Median hospital stay was 4.7 days. Patients who received a tracheostomy underwent decannulation with a median tracheostomy time of 5.5 days. Seven of 9 patients who received a percutaneous endoscopic gastrostomy tube had it removed. Three patients developed local recurrence, there were no regional recurrences, and 2 patients developed distant metastasis. Conclusions: Transoral resection of squamous cell carcinoma of the base of the tongue with postoperative adjuvant therapy provided excellent local and regional control and minimized morbidity. Transoral resection is a reasonable treatment option for patients with oropharyngeal squamous cell carcinoma, resulting in very low overall loss of organ function in properly selected patients.

AB - Objective: To review the oncologic and functional outcomes of patients with squamous cell carcinoma of the base of the tongue who underwent transoral tumor resection and neck dissection with or without postoperative adjuvant therapy. Design: Retrospective medical record review. Setting: Tertiary referral center. Patients: All patients undergoing transoral resection of squamous cell carcinoma on the base of the tongue as part of their primary treatment from January 1, 1996, through January 31, 2005. Main Outcome Measures: We analyzed overall survival, disease-specific survival, local control, and locoregional control rates using the Kaplan-Meier method. Speech and swallowing function and treatment-related morbidity were also analyzed. Results: A total of 20 patients underwent transoral resection. Four patients had surgery only, 12 had surgery and radiotherapy, and 4 had surgery and chemoradiotherapy. One patient had stage II disease, 3 had stage III disease, and 16 had stage IVA disease. The Kaplan-Meier overall survival rate was 90.0%, and the diseasespecific survival rate was 94.7% at 2 years, with a mean follow-up of 3.7 years. Median hospital stay was 4.7 days. Patients who received a tracheostomy underwent decannulation with a median tracheostomy time of 5.5 days. Seven of 9 patients who received a percutaneous endoscopic gastrostomy tube had it removed. Three patients developed local recurrence, there were no regional recurrences, and 2 patients developed distant metastasis. Conclusions: Transoral resection of squamous cell carcinoma of the base of the tongue with postoperative adjuvant therapy provided excellent local and regional control and minimized morbidity. Transoral resection is a reasonable treatment option for patients with oropharyngeal squamous cell carcinoma, resulting in very low overall loss of organ function in properly selected patients.

UR - http://www.scopus.com/inward/record.url?scp=73949083855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73949083855&partnerID=8YFLogxK

U2 - 10.1001/archoto.2009.177

DO - 10.1001/archoto.2009.177

M3 - Article

C2 - 20026821

AN - SCOPUS:73949083855

VL - 135

SP - 1231

EP - 1238

JO - JAMA Otolaryngology - Head and Neck Surgery

JF - JAMA Otolaryngology - Head and Neck Surgery

SN - 2168-6181

IS - 12

ER -